Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
31.05
+3.94 (14.53%)
At close: Aug 19, 2026, 4:00 PM EDT
31.85
+0.80 (2.58%)
Pre-market: Aug 20, 2026, 7:00 AM EDT
Scribe Therapeutics Market Cap
Scribe Therapeutics has a market cap or net worth of $585.74 million as of August 20, 2026.
Market Cap
585.74M
Enterprise Value
582.34M
1-Year Change
n/a
Ranking
Category
Stock Price
$31.05
ChartMarket Cap Chart
Since the IPO on July 24, 2026, Scribe Therapeutics's market cap has increased from $242.73M to $585.74M, an increase of 141.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 585.74M | 14.53% |
| Aug 18, 2026 | 511.41M | 27.94% |
| Aug 17, 2026 | 399.74M | 2.22% |
| Aug 14, 2026 | 391.06M | 1.77% |
| Aug 13, 2026 | 384.27M | -11.47% |
| Aug 12, 2026 | 434.07M | -1.83% |
| Aug 11, 2026 | 442.18M | -5.98% |
| Aug 10, 2026 | 470.29M | -4.12% |
| Aug 7, 2026 | 490.47M | 2.32% |
| Aug 6, 2026 | 479.34M | 6.76% |
| Aug 5, 2026 | 448.97M | 7.89% |
| Aug 4, 2026 | 416.15M | 5.88% |
| Aug 3, 2026 | 393.04M | 6.96% |
| Jul 31, 2026 | 367.48M | -4.51% |
| Jul 30, 2026 | 384.83M | 11.11% |
| Jul 29, 2026 | 346.35M | 1.66% |
| Jul 28, 2026 | 340.69M | -4.80% |
| Jul 27, 2026 | 357.86M | 47.43% |
| Jul 24, 2026 | 242.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 423.25M |
| Atea Pharmaceuticals | 418.67M |
| Fennec Pharmaceuticals | 414.84M |
| Compass Therapeutics | 414.17M |
| Lexeo Therapeutics | 411.85M |
| EyePoint | 411.23M |
| Upstream Bio | 398.73M |
| Foghorn Therapeutics | 392.54M |